Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Natural Killer Cell Therapy Product Introduction
1.2 Global Natural Killer Cell Therapy Market Size Forecast (2020-2031)
1.3 Natural Killer Cell Therapy Market Trends & Drivers
1.3.1 Natural Killer Cell Therapy Industry Trends
1.3.2 Natural Killer Cell Therapy Market Drivers & Opportunity
1.3.3 Natural Killer Cell Therapy Market Challenges
1.3.4 Natural Killer Cell Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Natural Killer Cell Therapy Players Revenue Ranking (2024)
2.2 Global Natural Killer Cell Therapy Revenue by Company (2020-2025)
2.3 Key Companies Natural Killer Cell Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Natural Killer Cell Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Natural Killer Cell Therapy
2.6 Natural Killer Cell Therapy Market Competitive Analysis
2.6.1 Natural Killer Cell Therapy Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Natural Killer Cell Therapy Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NK Cell Therapies
3.1.2 NK Cell Directed Antibodies
3.2 Global Natural Killer Cell Therapy Sales Value by Type
3.2.1 Global Natural Killer Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Natural Killer Cell Therapy Sales Value, by Type (2020-2031)
3.2.3 Global Natural Killer Cell Therapy Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Gastrointestinal Diseases
4.1.3 Others
4.2 Global Natural Killer Cell Therapy Sales Value by Application
4.2.1 Global Natural Killer Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Natural Killer Cell Therapy Sales Value, by Application (2020-2031)
4.2.3 Global Natural Killer Cell Therapy Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Natural Killer Cell Therapy Sales Value by Region
5.1.1 Global Natural Killer Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Natural Killer Cell Therapy Sales Value by Region (2020-2025)
5.1.3 Global Natural Killer Cell Therapy Sales Value by Region (2026-2031)
5.1.4 Global Natural Killer Cell Therapy Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Natural Killer Cell Therapy Sales Value, 2020-2031
5.2.2 North America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Natural Killer Cell Therapy Sales Value, 2020-2031
5.3.2 Europe Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Natural Killer Cell Therapy Sales Value, 2020-2031
5.4.2 Asia Pacific Natural Killer Cell Therapy Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Natural Killer Cell Therapy Sales Value, 2020-2031
5.5.2 South America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Natural Killer Cell Therapy Sales Value, 2020-2031
5.6.2 Middle East & Africa Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Natural Killer Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Natural Killer Cell Therapy Sales Value, 2020-2031
6.3 United States
6.3.1 United States Natural Killer Cell Therapy Sales Value, 2020-2031
6.3.2 United States Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Natural Killer Cell Therapy Sales Value, 2020-2031
6.4.2 Europe Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Natural Killer Cell Therapy Sales Value, 2020-2031
6.5.2 China Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.5.3 China Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Natural Killer Cell Therapy Sales Value, 2020-2031
6.6.2 Japan Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Natural Killer Cell Therapy Sales Value, 2020-2031
6.7.2 South Korea Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Natural Killer Cell Therapy Sales Value, 2020-2031
6.8.2 Southeast Asia Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Natural Killer Cell Therapy Sales Value, 2020-2031
6.9.2 India Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
6.9.3 India Natural Killer Cell Therapy Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Profile
7.1.2 Nektar Therapeutics Main Business
7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.1.5 Nektar Therapeutics Recent Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Profile
7.2.2 Innate Pharma SA Main Business
7.2.3 Innate Pharma SA Natural Killer Cell Therapy Products, Services and Solutions
7.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.2.5 Innate Pharma SA Recent Developments
7.3 Affimed
7.3.1 Affimed Profile
7.3.2 Affimed Main Business
7.3.3 Affimed Natural Killer Cell Therapy Products, Services and Solutions
7.3.4 Affimed Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.3.5 Affimed Recent Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Profile
7.4.2 Chipscreen Biosciences Main Business
7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Products, Services and Solutions
7.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.4.5 Chipscreen Biosciences Recent Developments
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Profile
7.5.2 Glycostem Therapeutics Main Business
7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
7.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.5.5 Glycostem Therapeutics Recent Developments
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Profile
7.6.2 Fate Therapeutics Main Business
7.6.3 Fate Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
7.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.6.5 Fate Therapeutics Recent Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Profile
7.7.2 Dragonfly Therapeutics Main Business
7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
7.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.7.5 Dragonfly Therapeutics Recent Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Profile
7.8.2 Kiadis Pharma Main Business
7.8.3 Kiadis Pharma Natural Killer Cell Therapy Products, Services and Solutions
7.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.8.5 Kiadis Pharma Recent Developments
7.9 Nkarta Therapeutics
7.9.1 Nkarta Therapeutics Profile
7.9.2 Nkarta Therapeutics Main Business
7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.9.5 Nkarta Therapeutics Recent Developments
7.10 NantKwest
7.10.1 NantKwest Profile
7.10.2 NantKwest Main Business
7.10.3 NantKwest Natural Killer Cell Therapy Products, Services and Solutions
7.10.4 NantKwest Natural Killer Cell Therapy Revenue (US$ Million) & (2020-2025)
7.10.5 NantKwest Recent Developments
8 Industry Chain Analysis
8.1 Natural Killer Cell Therapy Industrial Chain
8.2 Natural Killer Cell Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Natural Killer Cell Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Natural Killer Cell Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Natural Killer Cell Therapy Market Trends
Table 2. Natural Killer Cell Therapy Market Drivers & Opportunity
Table 3. Natural Killer Cell Therapy Market Challenges
Table 4. Natural Killer Cell Therapy Market Restraints
Table 5. Global Natural Killer Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Natural Killer Cell Therapy Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Natural Killer Cell Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Natural Killer Cell Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Natural Killer Cell Therapy
Table 10. Global Natural Killer Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Natural Killer Cell Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Natural Killer Cell Therapy Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Natural Killer Cell Therapy Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Natural Killer Cell Therapy Sales Market Share in Value by Type (2020-2025)
Table 17. Global Natural Killer Cell Therapy Sales Market Share in Value by Type (2026-2031)
Table 18. Global Natural Killer Cell Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Natural Killer Cell Therapy Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Natural Killer Cell Therapy Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Natural Killer Cell Therapy Sales Market Share in Value by Application (2020-2025)
Table 22. Global Natural Killer Cell Therapy Sales Market Share in Value by Application (2026-2031)
Table 23. Global Natural Killer Cell Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Natural Killer Cell Therapy Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Natural Killer Cell Therapy Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Natural Killer Cell Therapy Sales Value by Region (2020-2025) & (%)
Table 27. Global Natural Killer Cell Therapy Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Natural Killer Cell Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Natural Killer Cell Therapy Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Natural Killer Cell Therapy Sales Value, (2026-2031) & (US$ Million)
Table 31. Nektar Therapeutics Basic Information List
Table 32. Nektar Therapeutics Description and Business Overview
Table 33. Nektar Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Nektar Therapeutics (2020-2025)
Table 35. Nektar Therapeutics Recent Developments
Table 36. Innate Pharma SA Basic Information List
Table 37. Innate Pharma SA Description and Business Overview
Table 38. Innate Pharma SA Natural Killer Cell Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Innate Pharma SA (2020-2025)
Table 40. Innate Pharma SA Recent Developments
Table 41. Affimed Basic Information List
Table 42. Affimed Description and Business Overview
Table 43. Affimed Natural Killer Cell Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Affimed (2020-2025)
Table 45. Affimed Recent Developments
Table 46. Chipscreen Biosciences Basic Information List
Table 47. Chipscreen Biosciences Description and Business Overview
Table 48. Chipscreen Biosciences Natural Killer Cell Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Chipscreen Biosciences (2020-2025)
Table 50. Chipscreen Biosciences Recent Developments
Table 51. Glycostem Therapeutics Basic Information List
Table 52. Glycostem Therapeutics Description and Business Overview
Table 53. Glycostem Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Glycostem Therapeutics (2020-2025)
Table 55. Glycostem Therapeutics Recent Developments
Table 56. Fate Therapeutics Basic Information List
Table 57. Fate Therapeutics Description and Business Overview
Table 58. Fate Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Fate Therapeutics (2020-2025)
Table 60. Fate Therapeutics Recent Developments
Table 61. Dragonfly Therapeutics Basic Information List
Table 62. Dragonfly Therapeutics Description and Business Overview
Table 63. Dragonfly Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Dragonfly Therapeutics (2020-2025)
Table 65. Dragonfly Therapeutics Recent Developments
Table 66. Kiadis Pharma Basic Information List
Table 67. Kiadis Pharma Description and Business Overview
Table 68. Kiadis Pharma Natural Killer Cell Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Kiadis Pharma (2020-2025)
Table 70. Kiadis Pharma Recent Developments
Table 71. Nkarta Therapeutics Basic Information List
Table 72. Nkarta Therapeutics Description and Business Overview
Table 73. Nkarta Therapeutics Natural Killer Cell Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Natural Killer Cell Therapy Business of Nkarta Therapeutics (2020-2025)
Table 75. Nkarta Therapeutics Recent Developments
Table 76. NantKwest Basic Information List
Table 77. NantKwest Description and Business Overview
Table 78. NantKwest Natural Killer Cell Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Natural Killer Cell Therapy Business of NantKwest (2020-2025)
Table 80. NantKwest Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Natural Killer Cell Therapy Downstream Customers
Table 84. Natural Killer Cell Therapy Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts


List of Figures
Figure 1. Natural Killer Cell Therapy Product Picture
Figure 2. Global Natural Killer Cell Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Natural Killer Cell Therapy Sales Value (2020-2031) & (US$ Million)
Figure 4. Natural Killer Cell Therapy Report Years Considered
Figure 5. Global Natural Killer Cell Therapy Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Natural Killer Cell Therapy Revenue in 2024
Figure 7. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. NK Cell Therapies Picture
Figure 9. NK Cell Directed Antibodies Picture
Figure 10. Global Natural Killer Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Natural Killer Cell Therapy Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Cancer
Figure 13. Product Picture of Gastrointestinal Diseases
Figure 14. Product Picture of Others
Figure 15. Global Natural Killer Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Natural Killer Cell Therapy Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America Natural Killer Cell Therapy Sales Value (2020-2031) & (US$ Million)
Figure 18. North America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific Natural Killer Cell Therapy Sales Value by Region (%), 2024 VS 2031
Figure 23. South America Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa Natural Killer Cell Therapy Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions Natural Killer Cell Therapy Sales Value (%), (2020-2031)
Figure 28. United States Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 30. United States Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 34. China Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 35. China Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 36. China Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 46. India Natural Killer Cell Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 47. India Natural Killer Cell Therapy Sales Value by Type (%), 2024 VS 2031
Figure 48. India Natural Killer Cell Therapy Sales Value by Application (%), 2024 VS 2031
Figure 49. Natural Killer Cell Therapy Industrial Chain
Figure 50. Natural Killer Cell Therapy Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed